Results
1 -
10 of
33
(Click
here to explore results)
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 14 Ergot Alkaloids. Dorota Jakubczyk, Sarah O'Connor
, 2016
, Pages 379-397
- The Alkaloids: Volume 12, Indole alkaloids. M. F. Grundon, J. E. Saxton
, 1982
, Volume 12
, Pages 163-247
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 6 D3 Receptor Agonists and Antagonists as Anti‐Parkinsonian Therapeutic Agents. Mark Johnson, Aloke Dutta
, 2013
, Pages 126-148
- Emerging Drugs and Targets for Parkinson's Disease, Subject Index
, 2013
, Pages 390-402
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Contents
, 2016
, Pages P009-P018
- The Alkaloids: Volume 13, Indole alkaloids. M. F. Grundon, J. E. Saxton
, 1983
, Volume 13
, Pages 205-276
- The Alkaloids: Volume 8, Indole alkaloids. M. F. Grundon, J. E. Saxton
, 1978
, Volume 8
, Pages 149-215
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease. Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
- The Alkaloids: Volume 7, Indole alkaloids*. M. F. Grundon, J. E. Saxton
, 1977
, Volume 7
, Pages 183-246